Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-05-13
DOI
10.3389/fonc.2016.00109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives
- (2016) Joanne Chia et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer
- (2016) Srividya Venkitachalam et al. Scientific Reports
- The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy
- (2015) Jacques F.A.P. Miller et al. CANCER CELL
- Galectin-Binding O-Glycosylations as Regulators of Malignancy
- (2015) C. J. Dimitroff CANCER RESEARCH
- The role of active vaccination in cancer immunotherapy: lessons from clinical trials
- (2015) Haydn T Kissick et al. CURRENT OPINION IN IMMUNOLOGY
- Recent developments and future challenges in immune checkpoint inhibitory cancer treatment
- (2015) Bas D. Koster et al. CURRENT OPINION IN ONCOLOGY
- Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines
- (2015) Sònia Bassagañas et al. CYTOKINE
- Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin’s lymphoma
- (2015) Michele Merli et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Loss of α1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways
- (2015) Yuqin Wang et al. FASEB JOURNAL
- Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations
- (2015) Sandra Thiemann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment
- (2015) Wei Sun et al. MOLECULAR PHARMACEUTICS
- Glycan variation and evolution in the eukaryotes
- (2015) Anthony P. Corfield et al. TRENDS IN BIOCHEMICAL SCIENCES
- Pectin in cancer therapy: A review
- (2015) Wenbo Zhang et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling
- (2015) Yosuke Harazono et al. Oncotarget
- Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer
- (2015) Andréia Vasconcelos-dos-Santos et al. Frontiers in Oncology
- Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells
- (2015) Yosuke Harazono et al. Oncotarget
- Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo
- (2015) Vladislav V. Glinsky et al. NEOPLASIA
- Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
- (2015) Olga V. Glinskii et al. NEOPLASIA
- Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics
- (2014) Helen Blanchard et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- Abstract 33: OTX008 pharmacokinetics (PK) during the first-in-man phase I study in patients with advanced solid tumors .
- (2014) Keyvan Rezai et al. CANCER RESEARCH
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
- (2014) Kayluz Frias Boligan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes
- (2014) N. Demotte et al. CLINICAL CANCER RESEARCH
- OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
- (2014) Lucile Astorgues-Xerri et al. EUROPEAN JOURNAL OF CANCER
- Galectin-3 inhibitors: a patent review (2008–present)
- (2014) Helen Blanchard et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer
- (2014) Leonardo Mirandola et al. GYNECOLOGIC ONCOLOGY
- Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents
- (2014) GA BIN PARK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion
- (2014) S. R. Stowell et al. JOURNAL OF IMMUNOLOGY
- Design and Synthesis of Hydrolytically Stable Multivalent Ligands Bearing Thiodigalactoside Analogues for Peanut Lectin and Human Galectin-3 Binding
- (2014) Alejandro J. Cagnoni et al. JOURNAL OF ORGANIC CHEMISTRY
- Specific Glycosylation of Membrane Proteins in Epithelial Ovarian Cancer Cell Lines: Glycan Structures Reflect Gene Expression and DNA Methylation Status
- (2014) Merrina Anugraham et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting Prostate Carcinoma by G3-C12 Peptide Conjugated N-(2-Hydroxypropyl)methacrylamide Copolymers
- (2014) Yang Yang et al. MOLECULAR PHARMACEUTICS
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Increased expression ofGCNT1is associated with alteredO-glycosylation of PSA, PAP, and MUC1 in human prostate cancers
- (2014) Zuxiong Chen et al. PROSTATE
- Glycosaminoglycans in cancer treatment
- (2014) Mattias Belting THROMBOSIS RESEARCH
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
- (2013) Sørge Kelm et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Why anti-Bcl-2 clinical trials fail: a solution
- (2013) Y. Harazono et al. CANCER AND METASTASIS REVIEWS
- Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
- (2013) Massimo Zucchetti et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
- (2013) R. Tellez-Sanz et al. CURRENT MEDICINAL CHEMISTRY
- Altered Glycosylation in Tumours Focused to Cancer Diagnosis
- (2013) Rosa Peracaula et al. DISEASE MARKERS
- Cell surface protein glycosylation in cancer
- (2013) Maja N. Christiansen et al. PROTEOMICS
- Anti-cancer activities of pH- or heat-modified pectin
- (2013) Lionel Leclere et al. Frontiers in Pharmacology
- Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches
- (2013) Jose L. Daniotti et al. Frontiers in Oncology
- Siglecs and Immune Regulation
- (2012) Shiv Pillai et al. Annual Review of Immunology
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
- (2012) Koichi Ito et al. CLINICAL & EXPERIMENTAL METASTASIS
- Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide
- (2012) Jessica R. Newton-Northup et al. CLINICAL & EXPERIMENTAL METASTASIS
- GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
- (2012) N. Berois et al. CLINICAL CHEMISTRY
- 5-AZA-2'-deoxycytidine induced demethylation influencesN-glycosylation of secreted glycoproteins in ovarian cancer
- (2012) Radka Saldova et al. Epigenetics
- The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathway
- (2012) R. Takamiya et al. GLYCOBIOLOGY
- Carbohydrate-based cancer vaccines: target cancer with sugar bullets
- (2012) Chang-Cheng Liu et al. GLYCOCONJUGATE JOURNAL
- Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3
- (2012) Xiaoge Gao et al. GLYCOCONJUGATE JOURNAL
- Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
- (2012) Gabriel A. Rabinovich et al. IMMUNITY
- Synergistic and Additive Effects of Modified Citrus Pectin With Two Polybotanical Compounds, in the Suppression of Invasive Behavior of Human Breast and Prostate Cancer Cells
- (2012) Jiahua Jiang et al. INTEGRATIVE CANCER THERAPIES
- Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
- (2012) Diego O. Croci et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent
- (2012) Ju Bo Wang et al. PEPTIDES
- Defining putative glycan cancer biomarkers by MS
- (2012) Yehia Mechref et al. Bioanalysis
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
- (2011) Koichi Ito et al. ANGIOGENESIS
- Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates
- (2011) Yang Yang et al. BIOMATERIALS
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
- (2011) J. Ouyang et al. BLOOD
- High-Affinity Ligands of Siglec Receptors and their Therapeutic Potentials
- (2011) S. Magesh et al. CURRENT MEDICINAL CHEMISTRY
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- SIGLEC12, a Human-specific Segregating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas
- (2011) Nivedita Mitra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins
- (2011) Emma Salomonsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
- (2011) Filiberto Cedeno-Laurent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin
- (2011) E. O. KOZLOWSKI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Synthesis of 3-amido-3-deoxy-β-d-talopyranosides: all-cis-substituted pyranosides as lectin inhibitors
- (2011) Christopher T. Öberg et al. TETRAHEDRON
- Synthesis of fluorinated C-mannopeptides as sialyl Lewisx mimics for E- and P-selectin inhibition
- (2010) Vanessa Gouge-Ibert et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Synergy of 6-O-Sulfation andN- or 3-O-Sulfation of Chitosan Is Required for Efficient Inhibition of P-Selectin-Mediated Human Melanoma A375 Cell Adhesion
- (2010) Ruifei WANG et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- In vivo targeting of B-cell lymphoma with glycan ligands of CD22
- (2010) W. C. Chen et al. BLOOD
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Glycomics Hits the Big Time
- (2010) Gerald W. Hart et al. CELL
- PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and- Independent Prostate Cancer Cells
- (2010) Jun Yan et al. INTEGRATIVE CANCER THERAPIES
- Chemically Modified Heparin Inhibits In Vitro L-Selectin-Mediated Human Ovarian Carcinoma Cell Adhesion
- (2010) Zhihong Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Alterations in glycosylation as biomarkers for cancer detection
- (2010) C. A Reis et al. JOURNAL OF CLINICAL PATHOLOGY
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway
- (2010) P.-L. Kuo et al. JOURNAL OF IMMUNOLOGY
- Galectins as Cancer Biomarkers
- (2010) Vitaly Balan et al. Cancers
- Using pulse field gradient NMR diffusion measurements to define molecular size distributions in glycan preparations
- (2009) Michelle C. Miller et al. CARBOHYDRATE RESEARCH
- The -galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
- (2009) M. C Miller et al. GLYCOBIOLOGY
- Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
- (2009) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10
- (2009) Juan M Ilarregui et al. NATURE IMMUNOLOGY
- Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinoma
- (2009) Susan L. Deutscher et al. NUCLEAR MEDICINE AND BIOLOGY
- Proposal for a standard system for drawing structural diagrams ofN- andO-linked carbohydrates and related compounds
- (2009) David J. Harvey et al. PROTEOMICS
- Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
- (2009) Lars Petersen et al. THROMBOSIS AND HAEMOSTASIS
- Altered Glycosylation of Proteins in Cancer: What Is the Potential for New Anti-Tumour Strategies
- (2008) S. Brooks et al. Anti-Cancer Agents in Medicinal Chemistry
- Protein subtype-targeting through ligand epimerization: Talose-selectivity of galectin-4 and galectin-8
- (2008) Christopher T. Öberg et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Double Affinity Amplification of Galectin–Ligand Interactions through Arginine–Arene Interactions: Synthetic, Thermodynamic, and Computational Studies with Aromatic Diamido Thiodigalactosides
- (2008) Ian Cumpstey et al. CHEMISTRY-A EUROPEAN JOURNAL
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
- Expression of UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-6 in Gastric Mucosa, Intestinal Metaplasia, and Gastric Carcinoma
- (2008) Joana Gomes et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Galectin-1 Is a Novel Structural Component and a Major Regulator of H-Ras Nanoclusters
- (2008) Liron Belanis et al. MOLECULAR BIOLOGY OF THE CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search